Overview

ImmunitasBio is an immunodiagnostic company that aims to elevate human healthcare with a portfolio of cutting-edge and innovative solutions in the areas of immunology, inflammation, allergy, immuno-oncology and viral testing, catering to industries involved in the development of vaccines, biologics, diagnostics and FMCG products. ImmunitasBio was set up with the intent to advocate for the significance and need for immunological expertise and technical knowhow in overcoming COVID-19. The pandemic created an opportunity for us to offer vital support to vaccine manufacturers developing vaccines that harness both humoral and cellular immunity. We believe the expertise and capabilities built at ImmunitasBio, position us ideally to support the development of next generation healthcare tools that are heavily focused on cell-mediated immunity. Since inception in 2021, ImmunitasBio has successfully collaborated with big vaccine manufacturers and is now transitioning into immunotherapy, allergy, viral testing and FMCG products. Together with cutting-edge technology and deep science, we envision the creation of a healthier world, both nationally and globally.